• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破伤风类毒素疫苗的过度使用:尼泊尔一个常见但未得到充分解决的问题。

Overuse of tetanus toxoid vaccine: a common but under-addressed issue in Nepal.

作者信息

Shrestha Suraj, Aryal Roshan, Yadav Randhir S, Baidya Sujita, Acharya Suman, Bhandari Sanjeeb S

机构信息

Maharajgunj Medical Campus, Institute of Medicine, Kathmandu.

Kathmandu University School of Medical Sciences, Dhulikhel.

出版信息

Ann Med Surg (Lond). 2024 Sep 4;86(10):6276-6279. doi: 10.1097/MS9.0000000000002525. eCollection 2024 Oct.

DOI:10.1097/MS9.0000000000002525
PMID:39359813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11444576/
Abstract

INTRODUCTION AND IMPORTANCE

Tetanus, though potentially fatal, is preventable with proper vaccination, but high tetanus titers from frequent or higher doses can lead to increased adverse events. In countries like Nepal, where tetanus vaccines are readily available over the counter, irrational and frequent dosing, especially in certain occupational groups, is a noted issue.

CASE PRESENTATION

A 28-year-old metal worker presented with a superficial cut on his forearm, managed with standard wound care, and reported a history of frequent tetanus vaccinations. Given his extensive vaccination history, a tetanus toxoid injection was deemed unnecessary, and he was educated on proper vaccination schedules and advised to seek medical attention for future injuries.

CLINICAL DISCUSSION

Timely administration of vaccines for pre-exposure and postexposure prophylaxis is crucial for combating tetanus, with booster doses recommended every 10 years or as needed for wound management. High antibody titers from frequent tetanus vaccinations can increase the risk of adverse events, prompting guidelines to avoid administering Td more frequently than every 10 years unless necessary. Local reactions, like pain and swelling at the injection site, are common, while systemic reactions can include fever and peripheral neuropathy. Over-immunization is a concern in some regions, with frequent unnecessary booster doses potentially causing harm and highlighting the need for adherence to vaccination guidelines.

CONCLUSION

Modifying and monitoring adult Td booster vaccination can lead to significant cost savings and fewer adverse events, requiring proper vaccination record-keeping, accurate assessment, and adherence to guidelines by healthcare workers.

摘要

引言与重要性

破伤风虽然有潜在致命风险,但通过适当接种疫苗可预防,不过频繁接种或接种更高剂量导致破伤风抗体效价升高会增加不良事件发生几率。在尼泊尔等国家,破伤风疫苗可在柜台轻易购得,不合理且频繁接种,尤其是在某些职业群体中,是一个显著问题。

病例介绍

一名28岁金属工人因前臂浅表切割伤前来就诊,接受了标准伤口护理,其报告有频繁接种破伤风疫苗的病史。鉴于其广泛的疫苗接种史,认为无需注射破伤风类毒素,并对其进行了适当接种计划的教育,并建议其未来受伤时寻求医疗护理。

临床讨论

及时进行暴露前和暴露后预防接种疫苗对于预防破伤风至关重要,建议每10年接种加强针或根据伤口处理需要接种。频繁接种破伤风疫苗导致的高抗体效价会增加不良事件风险,促使指南建议除非必要,避免每10年以内更频繁地接种破伤风-白喉联合疫苗(Td)。局部反应,如注射部位疼痛和肿胀很常见,而全身反应可能包括发热和周围神经病变。过度免疫在一些地区是一个问题,频繁不必要的加强针可能造成伤害,凸显了遵守疫苗接种指南的必要性。

结论

调整和监测成人破伤风-白喉联合疫苗加强针接种可显著节省成本并减少不良事件,这需要医护人员妥善保存接种记录、进行准确评估并遵守指南。

相似文献

1
Overuse of tetanus toxoid vaccine: a common but under-addressed issue in Nepal.破伤风类毒素疫苗的过度使用:尼泊尔一个常见但未得到充分解决的问题。
Ann Med Surg (Lond). 2024 Sep 4;86(10):6276-6279. doi: 10.1097/MS9.0000000000002525. eCollection 2024 Oct.
2
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳(Tdap)疫苗与破伤风和白喉(Td)疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。
Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.
3
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.12种无细胞百日咳疫苗与1种全细胞百日咳疫苗作为第四剂,在15至20月龄儿童中接种的安全性和免疫原性比较。
Pediatrics. 1997 Nov;100(5):772-88. doi: 10.1542/peds.100.5.772.
4
Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.破伤风、白喉和无细胞百日咳(Tdap)疫苗在伤口管理中的使用对医疗保健费用和百日咳病例的影响。
J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c. doi: 10.18553/jmcp.2015.21.1.88.
5
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
6
Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.b型流感嗜血杆菌破伤风结合疫苗单独接种或与白喉-破伤风类毒素及无细胞百日咳疫苗混合接种用于初次免疫和加强免疫时的免疫原性和反应原性。
Eur J Pediatr. 1998 Mar;157(3):208-14. doi: 10.1007/s004310050797.
7
Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018.成人人群疫苗接种覆盖率监测-美国,2018 年。
MMWR Surveill Summ. 2021 May 14;70(3):1-26. doi: 10.15585/mmwr.ss7003a1.
8
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗(Boostrix®):作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
9
A randomized controlled trial [corrected] administration of tetanus toxoid (TT) versus tetanus and reduced diphtheria (Td) in pregnant women.一项关于孕妇接种破伤风类毒素(TT)与破伤风和白喉类毒素(Td)对比的随机对照试验[已修正]。
J Clin Immunol. 2009 Jul;29(4):524-31. doi: 10.1007/s10875-009-9289-5. Epub 2009 Apr 14.
10
Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination.葡萄牙成年女性接种成人型白百破疫苗前后白喉和破伤风特异性IgG水平。接种疫苗后的免疫持续时间。
BMC Public Health. 2007 Jun 12;7:109. doi: 10.1186/1471-2458-7-109.

本文引用的文献

1
The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines.SCARE 2023 指南:更新共识外科病例报告(SCARE)指南。
Int J Surg. 2023 May 1;109(5):1136-1140. doi: 10.1097/JS9.0000000000000373.
2
Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose.10 年前接种过一剂破伤风、白喉、无细胞百日咳疫苗(Tdap)的成人再次接种 Tdap 的安全性和免疫原性随机对照试验。
J Pediatric Infect Dis Soc. 2019 May 11;8(2):105-114. doi: 10.1093/jpids/pix113.
3
Tetanus vaccines: WHO position paper, February 2017 - Recommendations.破伤风疫苗:世卫组织立场文件,2017 年 2 月-建议。
Vaccine. 2018 Jun 14;36(25):3573-3575. doi: 10.1016/j.vaccine.2017.02.034. Epub 2017 Apr 18.
4
Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis.疫苗诱导的抗破伤风和白喉毒素免疫力的持久性:一项横断面分析。
Clin Infect Dis. 2016 May 1;62(9):1111-1118. doi: 10.1093/cid/ciw066. Epub 2016 Mar 21.
5
Eradication of tetanus.破伤风的根除
Br Med Bull. 2015;116(1):69-77. doi: 10.1093/bmb/ldv044. Epub 2015 Nov 22.
6
Immunity to tetanus and diphtheria in the UK in 2009.2009 年英国破伤风和白喉的免疫情况。
Vaccine. 2012 Nov 19;30(49):7111-7. doi: 10.1016/j.vaccine.2012.09.029. Epub 2012 Sep 26.
7
Shortened interval between tetanus vaccines.破伤风疫苗接种间隔缩短。
Ann Pharmacother. 2012 Jun;46(6):884-8. doi: 10.1345/aph.1Q651. Epub 2012 Jun 5.
8
Tetanus surveillance --- United States, 2001-2008.破伤风监测-美国,2001-2008 年。
MMWR Morb Mortal Wkly Rep. 2011 Apr 1;60(12):365-9.
9
Narrative review: tetanus-a health threat after natural disasters in developing countries.叙述性评论:破伤风——发展中国家自然灾害后的健康威胁。
Ann Intern Med. 2011 Mar 1;154(5):329-35. doi: 10.7326/0003-4819-154-5-201103010-00007.
10
The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.在先前破伤风疫苗接种后不到 2 年内接种破伤风-白喉-无细胞百日咳疫苗(Tdap)的安全性:在呼吸道疾病爆发期间进行的一次医疗保健人员大规模疫苗接种活动期间的经验。
Vaccine. 2010 Nov 23;28(50):8001-7. doi: 10.1016/j.vaccine.2010.09.034. Epub 2010 Sep 25.